SSGI (OTCMKTS:VICP) Stock Price Down 27.3% – What’s Next?

SSGI Inc. (OTCMKTS:VICP – Get Free Report)’s share price traded down 27.3% on Friday. The company traded as low as $0.40 and last traded at $0.40. Approximately 500 shares were traded during mid-day trading, a decline of 83% from the average daily volume of 2,947 shares. The stock had previously closed at $0.5499.

SSGI Stock Down 27.3%

The stock has a market capitalization of $12.83 million, a price-to-earnings ratio of -13.33 and a beta of 5.37. The stock has a fifty day moving average of $0.97 and a 200-day moving average of $1.29.

About SSGI

(Get Free Report)

Vicapsys Life Sciences, Inc focuses on the development and commercialization of VICAPSYN, a proprietary product. The company’s product is applied to transplantation therapies and related stem-cell applications in the transplantation field. It also develops VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of implantable medical devices and other implants to eliminate fibrosis, and wound healing with a focus on diabetic ulcers. The company was formerly known as Phage Therapeutics International, Inc and changed its name to Vicapsys Life Sciences, Inc in September 2017.

Read More

• Five stocks we like better than SSGI
• Bank of America Stock Sell-Off Looks Like a Buying Opportunity
• AST SpaceMobile Is Down 67%—Could SpaceX’s Mobile Push Deepen the Selloff?
• GlobalFoundries’ $21 Billion Deal Could Change the Economics of Chipmaking
• Fundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?